Company / Inventory
Zimmer Biomet Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$2.3B
FY2025
5-year range
$2.1B / $2.4B
FY2021-FY2025
Trend
+2.3%
vs FY2024
Sector context
#14 of 115
Health Care
What the data says
Zimmer Biomet's inventory of $2.3B is higher than 88% of companies in the Health Care sector (FY2025). Inventory has fluctuated over the past 10 years, ranging from $2.0B in FY2016 to $2.5B in FY2020.
Based on SEC 10-K filings.
$2.3B in FY2025 with a 5-year CAGR of -1.4%. Top quartile in the Health Care sector.
Declined from $2.4B to $2.3B over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +2.1%
- 5-Year CAGR
- -1.4%
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 115This company $2.3B Sector average $1.4B
▼
+62.8% above sector average
Key checks
Key Insights
- 5-year CAGR of -1.4%, indicating a declining trend.
- In FY2025, inventory increased 2.3% year-over-year.
- Ranks #14 out of 115 companies in the Health Care sector.
- Peak inventory was recorded in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.3B | +2.3% |
| FY2024 | $2.2B | -6.3% |
| FY2023 | $2.4B | +11.1% |
| FY2022 | $2.1B | -0.0% |
| FY2021 | $2.1B | -12.4% |
| FY2020 | $2.5B | +2.8% |
| FY2019 | $2.4B | +5.7% |
| FY2018 | $2.3B | +9.1% |
| FY2017 | $2.1B | +5.6% |
| FY2016 | $2.0B | -13.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026